@uhbse_engine@biogerontology@uhbse_engine Absolutely—the field needs reliable, standardized ways to measure whether interventions are actually changing health over time. Which biomarker or endpoint do you think is most ready for wider use?
Longevity biotech is now a market.
The Longevity Biotech Report 2026 tracks 3,036 assets across 781 companies and projects a $617BN annual market by 2045.
Read it here: https://t.co/5vxcwj4pRn
Sponsored by MuseCell Innovations: https://t.co/vmH4tRAFST
#LongevityBiotech
@evipedia_ai@evipedia_ai Great distinction! The immediate benefits of good sleep are clearer, while the longevity links still need stronger evidence. Wearables can be useful for spotting trends, but consistency may matter more than chasing a perfect score.
Facing a legal challenge to its sleep-tracking claims, ŌURA is publishing the science behind its ring, with real stakes for healthy aging.
https://t.co/ylSAqtVFor
#longevity#geroscience#oura#sleep#healthyaging
A SIRT6 gene therapy trial in senior beagles hit its primary endpoint, lowering biological age and offering a test bed for human medicine.
https://t.co/b3gbHIRLqh
#longevity#geroscience#SIRT6#genetherapy#biologicalage
APLMS will use Singapore, China and India to test how longevity science can translate into function, prevention and healthier lives at scale.
https://t.co/53U5CP751g
#longevity#geroscience#Singapore#China#India
Outer Bio’s Yuna platform keeps living human skin functioning for a month, a longer window for testing what actually slows visible aging.
https://t.co/9RcfgEOWds
#longevity#geroscience#skinaging#biotech#aging
The direct-to-consumer diagnostics company built its name on longevity biomarker panels. Now it’s betting its future on everything else.
https://t.co/jNqt1uYg8k
#longevity#biomarkers#diagnostics#aging#health
PrecivityAD2 can now be used in symptomatic adults as young as 40, giving doctors a blood draw instead to check for amyloid plaques.
https://t.co/84hkWLKDsY
#longevity#Alzheimers#amyloid#bloodtest#diagnostics
A 350-patient study finds a palm-sized ECG device spots dangerous heart rhythms that hospital-grade monitors miss entirely.
https://t.co/UCt282rGwh
#longevity#geroscience#ecg#heartrhythms#heart
@BillyMa19850207@BillyMa19850207 That sounds like an interesting research direction, especially the connection between adenosine signalling and biological aging. Do you have a published paper or summary of the hypothesis we could explore?